Back to search

University of Crete (UOC)

Ιmmune responses of alveolar epithelial cells

Abstract

dc:description

Group B Streptococcus (GBS) and SARS-CoV-2 represent significant respiratory pathogens with severe consequences for neonates and vulnerable individuals. GBS is a leading cause of neonatal pneumonia, sepsis, and meningitis, exploiting the immaturity of the neonatal immune system to invade the bloodstream. Despite its clinical significance, little is known about the role of alveolar epithelial cells in mounting an effective defense against GBS. In this study, we investigate the potential for enhancing alveolar epithelial cell-mediated immune responses against GBS through inhibition of the Akt kinase pathway. Our findings demonstrate that Akt inhibition enhances bacterial clearance via the induction of autophagy, increases inflammatory mediator production, and reduces both extracellular and intracellular bacterial loads. These mechanisms collectively strengthen the epithelial barrier and limit GBS invasion into the bloodstream, providing a novel therapeutic target for neonatal GBS infections. In parallel, the global SARS-CoV-2 pandemic has underscored the devastating impact of viral infections on pulmonary immune responses, particularly through the development of acute respiratory distress syndrome (ARDS) and cytokine storm. Our research focuses on the immunomodulatory effects of the SARS-CoV-2 spike (S) protein on macrophages and alveolar epithelial cells. We demonstrate that that SARS-CoV-2 promoted inflammatory cytokine expression and suppressed IRAK-M, rendering macrophages prone to increased responsiveness to TLR signals, supporting the development of cytokine storm observed in COVID-19 patients. Moreover, our findings may propose the use of Diminazene Aceturate (ACE2 activator) as a potential treatment for patients with COVID-19, since it is may reverse the pro-inflammatory actions of the virus. Conversely, in alveolar epithelial type II cells, SARS-CoV-2 S protein suppressed inflammatory responses at early stages of infection through activation of the PI3K/AKT pathway. These results suggest that at early stages SARS-CoV-2 S protein signals inhibit immune responses to the virus allowing it to propagate the infection while in combination with TLR2 signals enhances PAI-1 expression, potentially affecting the local coagulation cascade.Collectively, our findings highlight critical mechanisms by which alveolar epithelial cells and macrophages respond to GBS and SARS-CoV-2 infections. The modulation of Akt signaling in GBS infection and ACE2 activation in SARS-CoV-2 infection emerge as promising therapeutic strategies. Understanding these pathogen-specific immune interactions provides valuable insights for developing targeted interventions to mitigate severe respiratory infections and improve patient outcomes.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pantazi, Ioanna
  • Πανταζή, Ιωάννα

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60452

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pantazi, Ioanna; Πανταζή, Ιωάννα. Ιmmune responses of alveolar epithelial cells. University of Crete (UOC), 2025. http://hdl.handle.net/10442/hedi/60452